BSEAuro Laboratories LtdHighNeutral
Announced Fri, 30 May · 19:40 IST

Auro Laboratories Limited has submitted announcement for re-appointment of Internal Auditor.

Management Changes View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Auro Laboratories' board, at its May 30, 2025 meeting, appointed Mr. Kuntal Pancholi (29+ years of experience in accounts and finance) as the new Chief Financial Officer and Key Managerial Personnel effective the same date. The board also appointed M/s. Pokharna and Associates, Chartered Accountants (FRN: 151048W) as Internal Auditors for FY 2025-26 (April 1, 2025 to March 31, 2026). It approved audited financial results for Q4 and FY ended March 31, 2025, which show full-year revenue from operations of Rs. 1,939.84 lakhs versus Rs. 5,363.52 lakhs in FY24 — a sharp decline of roughly 64%. Profit after tax for FY25 fell to Rs. 183.88 lakhs (EPS Rs. 2.95) from Rs. 779.21 lakhs (EPS Rs. 12.50) in FY24. The statutory auditor M/s. Kothari Jain & Associates issued a clean (unmodified) opinion on the results.

Likely market impact

The steep year-on-year drop in revenue and profits is a negative signal for shareholders, but the clean audit opinion and fresh appointments of CFO and Internal Auditor point to stable governance. Note: the BSE headline mentions 're-appointment' of Internal Auditor, but the document describes a fresh appointment.